129 related articles for article (PubMed ID: 36116416)
21. Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies.
Schweitzer N; Vogel A
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):345-53. PubMed ID: 25966433
[TBL] [Abstract][Full Text] [Related]
22. Systemic and targeted therapy for biliary tract tumors and primary liver tumors.
Thomas MB
Surg Oncol Clin N Am; 2014 Apr; 23(2):369-81. PubMed ID: 24560115
[TBL] [Abstract][Full Text] [Related]
23. Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer.
Nakagawa H; Hayata Y; Yamada T; Kawamura S; Suzuki N; Koike K
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895797
[TBL] [Abstract][Full Text] [Related]
24. [Four Cases of Hepatectomy for Liver Metastases of Intractable Hepatobiliary Pancreatic Cancers].
Fujisaki S; Takashina M; Tomita R; Sakurai K; Takayama T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1451-3. PubMed ID: 26805060
[TBL] [Abstract][Full Text] [Related]
25. Future directions in the treatment of cholangiocarcinoma.
Zhu AX
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
[TBL] [Abstract][Full Text] [Related]
26. Molecular genetic positioning of small intestine and papilla of Vater carcinomas including clinicopathological classification.
Nakamura M; Okamura Y; Ohshima K; Sugiura T; Ashida R; Ohgi K; Bando E; Fujiya K; Shiomi A; Kagawa H; Imamura T; Nakayama G; Kodera Y; Uesaka K; Ohike N; Norose T; Sasaki K; Sugino T; Ohnami S; Nagashima T; Urakami K; Akiyama Y; Yamaguchi K
Cancer Med; 2023 May; 12(10):11491-11502. PubMed ID: 36999887
[TBL] [Abstract][Full Text] [Related]
27. BRCAness in biliary tract cancer: a new prognostic and predictive biomarker?
Hachem S; Kassis Y; Hachem MC; Zouein J; Gharios J; Kourie HR
Biomark Med; 2023 Jan; 17(1):51-57. PubMed ID: 36994675
[TBL] [Abstract][Full Text] [Related]
28. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
[TBL] [Abstract][Full Text] [Related]
29. Hepatobiliary cancers, version 2.2014.
Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
[TBL] [Abstract][Full Text] [Related]
30. Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers.
Harris WP; Wong KM; Saha S; Dika IE; Abou-Alfa GK
Semin Oncol; 2018 Jun; 45(3):116-123. PubMed ID: 30348531
[TBL] [Abstract][Full Text] [Related]
31. Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma.
Kobayashi S; Terashima T; Shiba S; Yoshida Y; Yamada I; Iwadou S; Horiguchi S; Takahashi H; Suzuki E; Moriguchi M; Tsuji K; Otsuka T; Asagi A; Kojima Y; Takada R; Morizane C; Mizuno N; Ikeda M; Ueno M; Furuse J
Cancer Sci; 2018 Aug; 109(8):2549-2557. PubMed ID: 29856900
[TBL] [Abstract][Full Text] [Related]
32. Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice.
Desjonqueres E; Campani C; Marra F; Zucman-Rossi J; Nault JC
Liver Int; 2022 Mar; 42(3):492-506. PubMed ID: 34982503
[TBL] [Abstract][Full Text] [Related]
33. SEOM clinical guidelines for pancreatic and biliary tract cancer (2020).
Gómez-España MA; Montes AF; Garcia-Carbonero R; Mercadé TM; Maurel J; Martín AM; Pazo-Cid R; Vera R; Carrato A; Feliu J
Clin Transl Oncol; 2021 May; 23(5):988-1000. PubMed ID: 33660222
[TBL] [Abstract][Full Text] [Related]
34. Esophageal metastasis of stem cell-subtype hepatocholangiocarcinoma: Rare presentation of a rare tumor.
Salimon M; Chapelle N; Matysiak-Budnik T; Mosnier JF; Frampas E; Touchefeu Y
World J Gastroenterol; 2018 Feb; 24(7):870-875. PubMed ID: 29467557
[TBL] [Abstract][Full Text] [Related]
35. New developments in systemic therapy for advanced biliary tract cancer.
Morizane C; Ueno M; Ikeda M; Okusaka T; Ishii H; Furuse J
Jpn J Clin Oncol; 2018 Aug; 48(8):703-711. PubMed ID: 29893894
[TBL] [Abstract][Full Text] [Related]
36. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.
Funabiki T; Matsubara T; Miyakawa S; Ishihara S
Langenbecks Arch Surg; 2009 Jan; 394(1):159-69. PubMed ID: 18500533
[TBL] [Abstract][Full Text] [Related]
37. Clinical treatment of cholangiocarcinoma: an updated comprehensive review.
Elvevi A; Laffusa A; Scaravaglio M; Rossi RE; Longarini R; Stagno AM; Cristoferi L; Ciaccio A; Cortinovis DL; Invernizzi P; Massironi S
Ann Hepatol; 2022; 27(5):100737. PubMed ID: 35809836
[TBL] [Abstract][Full Text] [Related]
38. "Biliary Diseases with Pancreatic Counterparts": Cross-sectional Imaging Findings.
Katabathina VS; Flaherty EM; Dasyam AK; Menias CO; Riddle ND; Lath N; Kozaka K; Matsui O; Nakanuma Y; Prasad SR
Radiographics; 2016; 36(2):374-92. PubMed ID: 26824512
[TBL] [Abstract][Full Text] [Related]
39. [The effect of R1 resection in the hepatobiliary pancreatic system].
Kolb A; Kleeff J; Friess H; Büchler MW
Chirurg; 2007 Sep; 78(9):802-9. PubMed ID: 17680231
[TBL] [Abstract][Full Text] [Related]
40. Genetics of hepatobiliary carcinogenesis.
Nault JC; Zucman-Rossi J
Semin Liver Dis; 2011 May; 31(2):173-87. PubMed ID: 21538283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
